Reports Q2 revenue $92.3M, consensus $67.86M. “We are pleased to announce another strong quarter, marked by growth across all our businesses. The hard work of our team and their dedication to serving transplant patients over the past year have been instrumental in our performance. As we approach the second half of the year, we remain focused on driving growth,” said John W. Hanna, CareDx President and CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
Questions or Comments about the article? Write to editor@tipranks.com